Hassiba Oubraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hassiba Oubraham has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Miere
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est Créteil, Créteil, France; and
1 shared publication Amel Bourroubey
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est Créteil, Créteil, France; and
1 shared publication- Camille Jung
Clinical Research Center, Centre Hospitalier Intercommunal de Créteil, Creteil, France
1 shared publication - Desire Kaoudio
Clinical Research Center, Centre Hospitalier Intercommunal de Créteil, Creteil, France
1 shared publication - Diana Ionita
Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est Créteil, Créteil, France; and
1 shared publication - Eric H. Souied
Service d'ophtalmologie, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94000 Créteil, France
1 shared publication
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (11) , 1910-1916
OUTCOMES AND HEALING PROCESS OF RETINAL PIGMENT EPITHELIAL TEARS IN PATIENTS WITH AMD
Purpose: To evaluate the incidence of retinal pigment epithelium (RPE) remodeling after RPE tears in age-related macular degeneration and assess its association with visual outcomes over a 5-year follow-up. Methods: This retrospective observational study reviewed age-related macular degeneration eyes with RPE tears and a minimum follow-up of 5 years. Changes in best-corrected visual acuity (BCVA) were recorded, and the presence and delay to development of tear-associated retinal pigment epithelial proliferation were evaluated. Results: Twenty-six eyes from 23 patients were included. The mean age was 80.08 ± 6.67 years. Baseline BCVA was 0.83 ± 0.52 logMAR (Snellen equivalent 20/125), and final BCVA declined to 1.05 ± 0.54 logMAR (20/200) ( P = 0.028). The mean follow-up was 6.25 ± 1.25 years. Both the greatest linear diameter and the area of RPE loss increased significantly from baseline to Year 5 ( P = 0.012 and P = 0.009, respectively). Tear-associated retinal pigment epithelial proliferation was observed in 54.2% of eyes at 5 years, with a mean onset of 293 ± 258 days. Final BCVA was significantly worse in eyes with subretinal hemorrhage ( P = 0.02), while the presence of tear-associated retinal pigment epithelial proliferation was not associated with visual outcome ( P = 0.21). At 5 years, BCVA declined in both groups (with and without tear-associated retinal pigment epithelial proliferation), with no significant difference ( P = 0.21). Conclusion: Approximately half of the eyes with RPE tears developed tear-associated retinal pigment epithelial proliferation, typically within the first year. Tear-associated retinal pigment epithelial proliferation did not confer a visual benefit. These findings suggest that anatomical remodeling of RPE tears may occur without translating into improved visual outcomes.
- 1 November 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (11) , 1910-1916
OUTCOMES AND HEALING PROCESS OF RETINAL PIGMENT EPITHELIAL TEARS IN PATIENTS WITH AMD
Purpose: To evaluate the incidence of retinal pigment epithelium (RPE) remodeling after RPE tears in age-related macular degeneration and assess its association with visual outcomes over a 5-year follow-up. Methods: This retrospective observational study reviewed age-related macular degeneration eyes with RPE tears and a minimum follow-up of 5 years. Changes in best-corrected visual acuity (BCVA) were recorded, and the presence and delay to development of tear-associated retinal pigment epithelial proliferation were evaluated. Results: Twenty-six eyes from 23 patients were included. The mean age was 80.08 ± 6.67 years. Baseline BCVA was 0.83 ± 0.52 logMAR (Snellen equivalent 20/125), and final BCVA declined to 1.05 ± 0.54 logMAR (20/200) ( P = 0.028). The mean follow-up was 6.25 ± 1.25 years. Both the greatest linear diameter and the area of RPE loss increased significantly from baseline to Year 5 ( P = 0.012 and P = 0.009, respectively). Tear-associated retinal pigment epithelial proliferation was observed in 54.2% of eyes at 5 years, with a mean onset of 293 ± 258 days. Final BCVA was significantly worse in eyes with subretinal hemorrhage ( P = 0.02), while the presence of tear-associated retinal pigment epithelial proliferation was not associated with visual outcome ( P = 0.21). At 5 years, BCVA declined in both groups (with and without tear-associated retinal pigment epithelial proliferation), with no significant difference ( P = 0.21). Conclusion: Approximately half of the eyes with RPE tears developed tear-associated retinal pigment epithelial proliferation, typically within the first year. Tear-associated retinal pigment epithelial proliferation did not confer a visual benefit. These findings suggest that anatomical remodeling of RPE tears may occur without translating into improved visual outcomes.